A carregar...
Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK
UK management costs for COPD, estimated at £1.9 billion/year, are rising. In the FULFIL (Lung Function and Quality of Life Assessment in Chronic Obstructive Pulmonary Disease with Closed Triple Therapy) study, single-inhaler triple therapy with fluticasone furoate/umeclidinium/vilanterol (100/62.5/2...
Na minha lista:
| Publicado no: | ERJ Open Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
European Respiratory Society
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7983252/ https://ncbi.nlm.nih.gov/pubmed/33778055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00480-2020 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|